Eva María Verdugo-Sivianes

7PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer geneticsTissue engineeringMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2025
Efficacy of NAMPT Inhibitors in Pancreatic Cancer After Stratification by MAP17 (PDZK1IP1) Levels.

Eva M Verdugo-Sivianes, Julia Martínez-Pérez, Lola E Navas

|Mar 29, 2023
Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?

Ana Amiama-Roig, Laura Pérez-Martínez, Pilar Rodríguez Ledo

|Oct 27, 2022
Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy.

Ana Amiama-Roig, Eva M Verdugo-Sivianes, Amancio Carnero

|May 14, 2022
A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer.

Javier Peinado-Serrano, Álvaro Quintanal-Villalonga, Sandra Muñoz-Galvan

|May 13, 2022
The circadian rhythm of viruses and its implications on susceptibility to infection.

José-Ramon Blanco, Eva M Verdugo-Sivianes, Ana Amiama

|Feb 03, 2022
CDH18 is a fetal epicardial biomarker regulating differentiation towards vascular smooth muscle cells.

Julia Junghof, Yuta Kogure, Tian Yu

Pageof 2